Table of Content




I. INTRODUCTION

Report Scope and Methodology
Executive Summary

II.BUSINESS ENVIRONMENT

Economic Outlook

Key Economic Indicators
Industrial Sales Volume
Population and Labor
Foreign Investment
Foreign Trade

Financial and Tax Regulations

Banking System and Regulations
Foreign Exchange
Taxes, Tariff and Custom Duties

II. ANTI-OBESITY DRUGS INDUSTRY ASSESSMENTS

Anti-Obesity Drugs Industry Structure
Market Size
Market Growth Drivers
Anti-Obesity Drugs Industry
Major Producer Facility Locations and Sales Volume
Locations
Sales Volume
Market Share of Key Producers
Labor Cost
Potential Entrants
Major Distributors
Major Foreign Investments
Technology Development

V. ANTI-OBESITY DRUGS PRODUCTION AND DEMAND
Overview
Demand of Anti-Obesity Drugs by Region
Anti-Obesity Drugs Production and Demand
Sibutramine
Major Manufacturers
Supply and Demand
Traditional Chinese Medicine
Major Manufacturers
Supply and Demand
Orlistat
Major Manufacturers
Supply and Demand
Rimonabant
Major Manufacturers
Supply and Demand
Metformin
Major Manufacturers
Supply and Demand
Other Anti-Obesity Drugs

Anti-Obesity Drugs Imports and Exports
Anti-Obesity Drugs Imports
Anti-Obesity r Drugs Exports
Pricing Trend

V. ANTI-OBESITY DRUGS MARKET OUTLOOK
Anti-Obesity Drugs Markets Outlook Overview
Government Regulation
Health Care Insurance Industry Overview
Consumer Spending Trends
Demographic Trends
Health Care Industry Trends
Hospitals and Hospital Beds
Physicians and Physician Visits

I. MARKETING STRATEGIES

China Market Entry Overview
China’s Distribution System
Rubber Processing Chemicals Distribution Channels
Transportation and Freight Infrastructure
Communications
China’s Market Entry
Licensing
Franchising
E-commerce
Trading Companies and Local Agents
Representative Offices and Chinese Subsidiaries
Wholly Foreign Owned Enterprises

II. ANTI-OBESITY DRUGS PRODUCER DIRECTORY

Profiles of Anti-Obesity Drugs Producers and Major Suppliers





List of Tables

I. INTRODUCTION

Economic Outlook Summary

I. BUSINESS ENVIRONMENT

Key Economic Indicators
Industrial Sales Volume
Population and Labor Force Trends
Foreign Investment and Loans
Foreign Trade

II. ANTI-OBESITY TREATMENT DRUGS INDUSTRY ASSESSMENTS

Anti-Obesity Drugs Industry Sales Volume
Major Producer Facility Location
Major Anti-Obesity Drugs Producer Sales Volume
Market Share of Key Producers
Major Foreign Investment in China

V. ANTI-OBESITY DRUGS PRODUCTION AND DEMAND

Anti-Obesity Drugs Production and Demand
Demand of Anti-Obesity Drugs by Region
Major Sibutramine Producer Sales Volume
Sibutramine Drugs Production and Demand
Major Traditional Chinese medicine Producer Sales Volume
Traditional Chinese Medicine Production and Demand
Major Orlistat Producer Sales Volume
Olistat Production and Demand
Rimonabant Production and Demand
Major Metformin Producer Sales Volume
Metformin Production and Demand
Other Anti-obesity Drugs Production and Demand
China Anti-Obesity Drugs Imports and Exports


V. ANTI-OBESITY DRUGS MARKET OUTLOOK

Total Anti-Obesity Drugs Sales Volume by Market
Consumer Spending Trend
Demographic Trends
Health Care Industry Trends
Hospitals and Hospital Beds
Physicians and Physician Visits





LIST OF CHARTS

I. INTRODUCTION

China’s Anti-Obesity Drugs Sales Volume, Demand

I. BUSINESS ENVIRONMENT

China’s GDP and Growth Rate
Industrial Sales Volume by Ownership
China’s Imports and Exports

II. ANTI-OBESITY DRUGS INDUSTRY ASSESSMENTS

All kinds of Anti-Obesity Drugs Market Share
Anti-Obesity Drugs Sales Volume and Demand

V. ANTI-OBESITY DRUGS PRODUCTION AND DEMAND

Total Anti-Obesity Drugs Production and Demand
Total Anti-Obesity Drugs Imports and Exports

V. ANTI-OBESITY DRUGS MARKET OUTLOOK

Anti-Obesity Drugs Sales Volume by Market

I. MARKETING STRATEGIES
China’s Distribution Channel